Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Pharmacology, Early Phase Trials

Timothy A. Yap

MBBS, PhD, FRCP

🏢MD Anderson Cancer Center🌐USA

Professor and Vice President of Clinical Development

70
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Timothy Yap leads early phase trials at MD Anderson with a focus on DDR-targeted agents, PARP inhibitor combinations, and novel immuno-oncology mechanisms. He has directed dozens of first-in-human studies and helped define optimal biological dosing strategies. His work integrates translational pharmacology with adaptive trial design.

Share:

🧪Research Fields 研究领域

phase I oncology
DNA damage response
PARP inhibitors
drug development
investigational therapeutics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Timothy A. Yap 的研究动态

Follow Timothy A. Yap's research updates

留下邮箱,当我们发布与 Timothy A. Yap(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment